Trevena Added to Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
CHESTERBROOK, Pa., June 28, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced…
